2008
Hormonal Contraception and HIV‐Positive Women: Metabolic Concerns and Management Strategies
Womack J, Richman S, Tien PC, Grey M, Williams A. Hormonal Contraception and HIV‐Positive Women: Metabolic Concerns and Management Strategies. Journal Of Midwifery & Women's Health 2008, 53: 362-375. PMID: 18586190, PMCID: PMC2776678, DOI: 10.1016/j.jmwh.2008.01.006.Peer-Reviewed Original ResearchConceptsHIV-positive womenMore HIV-positive womenHormonal contraceptionMetabolic dysfunctionMetabolic dysregulationLong-term complicationsPresence of HIVAdditive side effectsHIV seropositivityMetabolic concernsReversible contraceptionSide effectsHIVContraceptionWomenComplicationsDysfunctionDysregulationManagement strategiesClinicians
2005
Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment
Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks SG. Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment. Journal Of Virology 2005, 79: 14169-14178. PMID: 16254352, PMCID: PMC1280210, DOI: 10.1128/jvi.79.22.14169-14178.2005.Peer-Reviewed Original ResearchConceptsHIV-specific T cellsT cellsT cell activationHIV diseaseImmune activationHuman immunodeficiency virus (HIV) replicationAdvanced HIV diseaseDrug-resistant viremiaGeneralized immune activationHIV-specific ILMultidrug-resistant HIVQuiescent immune systemActive antiretroviral therapyCytokine flow cytometryT cell controlHigh-level viremiaLow-level viremiaPresence of HIVT cell subsetsHuman immunodeficiency virusImmunodeficiency virus replicationT cell subpopulationsAbsence of therapyPresence of therapyAntiretroviral therapy
1998
Acceptance and Adherence With Antiretroviral Therapy Among HIV-Infected Women in a Correctional Facility
Mostashari F, Riley E, Selwyn P, Altice F. Acceptance and Adherence With Antiretroviral Therapy Among HIV-Infected Women in a Correctional Facility. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 341-348. PMID: 9704939, DOI: 10.1097/00042560-199808010-00005.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyAntiretroviral agentsCare systemHIV-seropositive womenPresence of HIVNon-black racePatient-physician relationshipHealth care systemMedical care systemHIV careHIV medicationsMedication adherenceMedication efficacyMedication safetyHIVMultivariate analysisTherapyAdherenceHealth careWomenCareMedicationsEducational levelStructured interviewsSocial support
1991
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS
STUDY T, Graham N, Zeger S, Park L, Saah A, Phair J, Detels R, Vermund S, Ho M. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Lancet 1991, 338: 265-269. PMID: 1677108, DOI: 10.1016/0140-6736(91)90414-k.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAerosolsCD4-Positive T-LymphocytesEvaluation Studies as TopicFollow-Up StudiesHIV SeropositivityHIV-1HumansLeukocyte CountMalePentamidinePneumonia, PneumocystisProspective StudiesRegression AnalysisRisk FactorsTime FactorsTrimethoprim, Sulfamethoxazole Drug CombinationZidovudineConceptsPneumocystis carinii pneumoniaEffect of zidovudineHIV-1 infectionPCP prophylaxisProbability of progressionLymphocytes/First episodePneumocystis carinii pneumonia prophylaxisHIV-1-infected individualsHIV-1-seropositive menMonth intervalsPrimary PCP prophylaxisEfficacy of zidovudinePresence of HIVRate of progressionMultivariate log-linear modelPneumonia prophylaxisMore CD4Primary prophylaxisZidovudine therapyLymphocyte countCarinii pneumoniaClinical trialsObservational studyProphylaxis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply